Treating gestational diabetes reduces perinatal morbidityBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2690 (Published 14 April 2014) Cite this as: BMJ 2014;348:g2690
- Kenneth K Hodson, subspecialty trainee in maternal and fetal medicine1,
- Malcolm W J MacDougall, consultant obstetrician1,
- Roy Taylor, professor of metabolic medicine and metabolism2
- 1Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
- 2University of Newcastle upon Tyne, Newcastle upon Tyne, UK
The recent analysis of gestational diabetes summarises the ongoing debate about whether to screen for and treat this condition.1 The authors conclude that mild glycaemia “does not carry anything like the same degree of risk” (as pre-existing type 1 or 2 diabetes) and imply that treating gestational diabetes has no clinically important benefit.
Two randomised controlled trials have established the benefit …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial